Winton Gibbons

Consultant. Innovative medical diagnostics, novel biomarkers, digital health, medtech, and biotech. Prior McKinsey, industry executive, and stock analyst.

[Winton Gibbons @wingibbons]

@VPrasadMDMPH Science always seems most likely to fall prey to “those who don’t learned history are doomed to repeat it.

[Winton Gibbons @wingibbons]

@VPrasadMDMPH @Amgen I heard something similar at an on site AbbVie conference. The company showed visible anger to the academic scientists assembled.

[Winton Gibbons @wingibbons]

@DTWillingham Agreed. The same prompt (if it’s for a real task) will return different results, often quite different. And certainly OpenAI is always tinkering, obviating even reproducible approaches.

[Winton Gibbons @wingibbons]

@KonstantinKisin Indeed

[Winton Gibbons @wingibbons]

PinkDx sounds like it is getting it right from the start: #clinicalrigor #multiomics #machinelearning

Also home their is an early focus on #marketaccess #reimbursement

Good luck!!

https://t.co/hEQjADSlTk

[360Dx @360DxNews]

Payors, Labs Parsing State Biomarker Testing Laws to Better Understand Coverage Mandates. Laws passed in 14 states appear to require commercial payors to cover biomarker tests broadly that meet certain evidentiary criteria, but payors may have a... https://t.co/61t80Qg41n

[Winton Gibbons @wingibbons]

Rather #counterintuitive “Chat” on #AGI #superAGI

https://t.co/OAOme5Qldz

#STEM #biotechnology #lifesciencetools #cancer #medicine

[Winton Gibbons @wingibbons]

@AppleHelix Agreed. How on earth would those studies be funded? Is there some "if, then;" whereby, the USPTO says if a study meets some particular endpoint that the patent is then automatically granted?

[Winton Gibbons @wingibbons]

@JAMA_current Shape matters, not just AUC, in many cases more. Why are there no ROC curves shown? Also, the use of ROC curves, which are prevalence independent, ignores positive ("rule-in") and negative ("rule-out") predicitve values. Without those, AUCs, low or high, cannot really be judged.

[Winton Gibbons @wingibbons]

#ChatGPT fatally flawed by propagating (expands?) scientific publication bias (#GPT-3 itself agrees a huge problem). Need severe warning, not just “I might be wrong.” Betting it leads to stronger status quo, less new knowledge. #retraction #publicationbias #reproducibilitycrisis

[Winton Gibbons @wingibbons]

https://t.co/LsLq5OnJdz

Useful for #IVD R&D. Many studies replicate poorly, and this delays progress, both scientifically and economically.

#precisionmedicine #AACC #Dx #omics #cancer #biomarkers #companiondiagnostics #CDx #proteomics #bioinformatics #genomics #medtech #biotech

[Numares Health @AgNumares]

European Investment Bank Finances Innovative Diagnostics Developer #Numares Health with €20 Million

Numares develops precision multi-biomarker diagnostic tests for patients with chronic kidney, heart and liver disease.

https://t.co/LjBnUsdBkc

https://t.co/qYyU3Ifmww

[Winton Gibbons @wingibbons]

#Numares and #MayoClinic deepen its collaboration for patient care in #metabolic & #inflammatory conditions as #Mayo invests in numares with a convertible equity investment.

Together, we work to create #NMR #metabolomic tests to help physicians better care for their patients.

[Numares Health @AgNumares]

Numares Health and Mayo Clinic Strengthening Collaboration for Improved Diagnostic Tests

https://t.co/e7eGZJxz65

[Numares Health @AgNumares]

https://t.co/xocpDMGZPW

[Winton Gibbons @wingibbons]

numares is committed to #kidneycare nationally and locally near our US headquarters in #TheWoodlands, Texas.

[Numares Health @AgNumares]

#SeasonGreetings with best #biomarkerconstellations #2022.
#numares is #donating @nkf #TexasKidneyWalk to help enable the future of #kidneydisease. @NKFTexas allows us to locally benefit #patient services near our new office location in #TheWoodlands, TX. #kidney #gfr #AXINON

[Winton Gibbons @wingibbons]

What a great addition to the #numares Supervisory Board. Greg brings decades of #diagnostics and #omics experience from #Illumina and #Roche.

[Numares Health @AgNumares]

#numares elects Dr. Gregory F. Heath as new member of the Supervisory Board effective January 1st.
Press release: https://t.co/28hCW9Wc2x

#biomarker #biomarkerconstellations #precisionmedicine #precisiondiagnostics #medtech #investment #MGS #innovationinhealthcare #kidney

[Winton Gibbons @wingibbons]

numares continues to drive #metabolomics and #multiomics into routine clinical use. Easy-to-use NMR. Great employees enabling.

[Numares Health @AgNumares]

#numares insider 7: Exclusive License Agreement for Multimarker #MultipleSclerosis Diagnostics / Experts view on #CVD #Diagnostics by #lipoprotein particle analysis / Expanding Diagnostic Applications of #NMRspectroscopy #metabolomics #laboratorymedicine #biomarker #AI #NMR #MS

[Numares Health @AgNumares]

#numaresNews: Detection of #MS disease progression is still a diagnostic gap. Excellent scientific work of @UniofOxford and #numares #NMR #diagnostics combining #biomarkers may change how #multiplesclerosis #patients are diagnosed & treated:
Read more: https://t.co/SKx9Lwncyl

[Winton Gibbons @wingibbons]

@AppleHelix The data is so dramatic and "perfect" that perhaps the hypothesis should more likely be an issue with sample or data handling.

[Winton Gibbons @wingibbons]

Here is another positive milestone for #numares as we continue to build momentum. We also expect to file another 510k application to the #FDA this year for our #kidney function assay.

#metabolomics #precisionmedicine #invitrodiagnostics #cardiacdisease

https://t.co/S34GCtK0gx